TY - CHAP
T1 - MicroRNA Dysregulation in Aging and Pathologies of the Skeletal Muscle
AU - McCormick, Rachel
AU - Goljanek-Whysall, Katarzyna
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018
Y1 - 2018
N2 - Skeletal muscle is one of the biggest organs of the body with important mechanistic and metabolic functions. Muscle homeostasis is controlled by environmental, genetic, and epigenetic factors. Indeed, MiRNAs, small noncoding RNAs robust regulators of gene expression, have and have been shown to regulate muscle homeostasis on several levels: through controlling myogenesis, muscle growth (hypertrophy) and atrophy, as well as interactions of muscle with other tissues. Given the large number of MiRNA target genes and the important role of MiRNAs in most physiological processes and various diseases, MiRNAs may have an enormous potential as therapeutic targets against numerous disorders, including pathologies of muscle. The purpose of this review is to present the current knowledge of the role of MiRNAs in skeletal muscle homeostasis and pathologies and the potential of MiRNAs as therapeutics for skeletal muscle wasting, with particular focus on the age- and disease-related loss of muscle mass and function.
AB - Skeletal muscle is one of the biggest organs of the body with important mechanistic and metabolic functions. Muscle homeostasis is controlled by environmental, genetic, and epigenetic factors. Indeed, MiRNAs, small noncoding RNAs robust regulators of gene expression, have and have been shown to regulate muscle homeostasis on several levels: through controlling myogenesis, muscle growth (hypertrophy) and atrophy, as well as interactions of muscle with other tissues. Given the large number of MiRNA target genes and the important role of MiRNAs in most physiological processes and various diseases, MiRNAs may have an enormous potential as therapeutic targets against numerous disorders, including pathologies of muscle. The purpose of this review is to present the current knowledge of the role of MiRNAs in skeletal muscle homeostasis and pathologies and the potential of MiRNAs as therapeutics for skeletal muscle wasting, with particular focus on the age- and disease-related loss of muscle mass and function.
KW - Aging
KW - Disease
KW - MicroRNA
KW - Muscle
UR - http://www.scopus.com/inward/record.url?scp=85017416479&partnerID=8YFLogxK
U2 - 10.1016/bs.ircmb.2017.03.005
DO - 10.1016/bs.ircmb.2017.03.005
M3 - Chapter
C2 - 28838540
AN - SCOPUS:85017416479
T3 - International Review of Cell and Molecular Biology
SP - 265
EP - 308
BT - International Review of Cell and Molecular Biology
PB - Elsevier Inc.
ER -